HealthStream (NASDAQ:HSTM) Announces Quarterly Earnings Results

HealthStream (NASDAQ:HSTM) released its quarterly earnings results on Monday. The technology company reported $0.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.17 by $0.03, Zacks reports. HealthStream had a return on equity of 5.70% and a net margin of 6.89%.The business had revenue of $76.47 million during the quarter, compared to analyst estimates of $75.52 million. HealthStream updated its FY 2025 guidance to EPS.

HealthStream Trading Up 2.9%

Shares of HSTM opened at $25.32 on Tuesday. The business’s 50 day moving average is $27.48 and its 200 day moving average is $27.82. The company has a market capitalization of $750.51 million, a PE ratio of 37.79, a price-to-earnings-growth ratio of 3.08 and a beta of 0.47. HealthStream has a 12-month low of $24.07 and a 12-month high of $34.24.

HealthStream Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 28th. Investors of record on Monday, November 17th will be paid a dividend of $0.031 per share. This represents a $0.12 annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend is Monday, November 17th. HealthStream’s dividend payout ratio (DPR) is 17.91%.

Insider Activity at HealthStream

In related news, EVP Kevin P. O’hara sold 2,000 shares of the business’s stock in a transaction dated Wednesday, August 27th. The stock was sold at an average price of $27.97, for a total value of $55,940.00. Following the sale, the executive vice president directly owned 17,137 shares in the company, valued at approximately $479,321.89. The trade was a 10.45% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 20.50% of the company’s stock.

Institutional Investors Weigh In On HealthStream

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in HSTM. JPMorgan Chase & Co. raised its position in HealthStream by 302.0% during the second quarter. JPMorgan Chase & Co. now owns 247,905 shares of the technology company’s stock valued at $6,860,000 after purchasing an additional 186,231 shares during the period. Qube Research & Technologies Ltd raised its holdings in shares of HealthStream by 77.3% in the second quarter. Qube Research & Technologies Ltd now owns 251,953 shares of the technology company’s stock worth $6,972,000 after buying an additional 109,883 shares during the period. Bank of America Corp DE raised its holdings in shares of HealthStream by 56.2% in the second quarter. Bank of America Corp DE now owns 141,282 shares of the technology company’s stock worth $3,909,000 after buying an additional 50,852 shares during the period. Jane Street Group LLC purchased a new stake in shares of HealthStream in the first quarter worth approximately $1,532,000. Finally, Royal Bank of Canada raised its holdings in shares of HealthStream by 194.2% in the first quarter. Royal Bank of Canada now owns 43,899 shares of the technology company’s stock worth $1,413,000 after buying an additional 28,977 shares during the period. 69.58% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several analysts have issued reports on HSTM shares. Canaccord Genuity Group cut their price target on HealthStream from $29.00 to $28.00 and set a “hold” rating for the company in a report on Thursday, August 7th. Weiss Ratings reissued a “hold (c)” rating on shares of HealthStream in a report on Wednesday, October 8th. One analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $28.00.

HealthStream Company Profile

HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company’s solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.